No segmentation disclosed for this filer. n/a
Manzo Pharmaceuticals, Inc. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Financial Services companies we track, at a -Infinity% net margin.
No filings loaded — no CIK (non-SEC filer).